Acarbose is an alpha-glucosidase inhibitor and starch blocker used in the treatment of type 2 diabetes by preventing the enzymatic breakdown of complex carbohydrates into glucose in the intestine. Because… Read more












Acarbose is an alpha-glucosidase inhibitor and starch blocker used in the treatment of type 2 diabetes by preventing the enzymatic breakdown of complex carbohydrates into glucose in the intestine. Because this agent is a complex oligosaccharide derived from microbial fermentation, pharmaceutical laboratories require high-quality reference standards for comprehensive quality control and regulatory compliance. This category provides access to the active pharmaceutical ingredient, alongside a comprehensive range of pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope labelled compounds. These materials are essential for accurate impurity profiling, supporting analytical method validation, and conducting stability studies in accordance with international guidelines. Whether identifying specific degradation pathways or performing system suitability testing, these standards ensure reliable performance in analytical workflows for the accurate assessment and quality assurance of this anti-diabetic medication.